Gian Piero Reverberi

2017

In 2017, Gian Piero Reverberi earned a total compensation of $2.1M as Senior Vice President, Chief Commercial Officer at Vanda Pharmaceuticals, a 21% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$203,622
Option Awards$728,203
Salary$486,553
Stock Awards$565,500
Other$81,595
Total$2,065,473

Reverberi received $728.2K in option awards, accounting for 35% of the total pay in 2017.

Reverberi also received $203.6K in non-equity incentive plan, $486.6K in salary, $565.5K in stock awards and $81.6K in other compensation.

Rankings

In 2017, Gian Piero Reverberi's compensation ranked 5,341st out of 14,666 executives tracked by ExecPay. In other words, Reverberi earned more than 63.6% of executives.

ClassificationRankingPercentile
All
5,341
out of 14,666
64th
Division
Manufacturing
1,912
out of 5,772
67th
Major group
Chemicals And Allied Products
570
out of 2,075
73rd
Industry group
Drugs
440
out of 1,731
75th
Industry
Pharmaceutical Preparations
347
out of 1,333
74th
Source: SEC filing on April 27, 2018.

Reverberi's colleagues

We found four more compensation records of executives who worked with Gian Piero Reverberi at Vanda Pharmaceuticals in 2017.

2017

Mihael Polymeropoulos

Vanda Pharmaceuticals

Chief Executive Officer

2017

James Kelly

Vanda Pharmaceuticals

Chief Financial Officer

2017

Gunther Birznieks

Vanda Pharmaceuticals

Senior Vice President, Business Development

2017

Richard Gulino

Vanda Pharmaceuticals

General Counsel

News

You may also like